Home / ARGNF : OTC

AI Analysis Fundamentals Valuation Video Analysis News Similar

AI Analysis

How does ARGNF make money? Does ARGNF have pricing power? What's the Earnings Whisper? Will ARGNF profit more as the business scales? What is ARGNF's management track record? Is ARGNF's current price justified?

argenx SE

$1010.26 +$140.26 (+16.12%)

OTC · 11 Sep 2026 20:00 UTC

Previous Close

$1010.26

Day Range

$995$1010.26

Year Range

$712.02$1020

Market Cap

62.83B

AVG Volume

Trailing/Forward PE

36.44/25.84

PEG ratio

1.03

Dividend Yield

Next Earnings Date

2026-10-22

Primary Exchange

Other OTC

PE Ratio

ARGNF PE Ratio by quarter
Period	PE Ratio
Sep 26	42.28
Sep 26	42.44
Aug 26	42.68
Aug 26	41.64
Aug 26	36.32
Aug 26	36.2
Jul 26	36.2
Jul 26	36.2
Jul 26	36.2
Jul 26	39.14
Jul 26	39.14
Jun 26	37.66
Jun 26	37.66
Jun 26	37.66
Jun 26	34.94
May 26	34.94
May 26	33.61
May 26	33.61
May 26	33.61
May 26	30.32
Apr 26	32.68
Apr 26	37.44
Apr 26	29.8
Apr 26	29.8
Mar 26	89.79
Mar 26	89.79
Mar 26	89.79
Mar 26	89.79
Feb 26	89.79
Feb 26	89.79
Feb 26	89.79
Feb 26	92.78
Jan 26	92.78
Jan 26	90.01
Jan 26	90.01
Jan 26	90.01
Jan 26	95.86
Dec 25	95.86
Dec 25	95.86
Dec 25	95.86
Dec 25	95.86
Nov 25	95.86
Nov 25	95.86
Nov 25	95.86
Nov 25	92.55
Oct 25	86.61
Oct 25	91.84
Oct 25	91.84
Oct 25	91.84
Oct 25	88.15
Sep 25	318.99
Sep 25	318.99
Sep 25	318.99
Sep 25	272.39
Aug 25	272.39
Aug 25	246.99
Aug 25	246.99
Aug 25	218.35
Aug 25	218.35
Jul 25	218.35
Jul 25	218.35
Jul 25	218.35
Jul 25	218.35

Free Cash Flow Yield

ARGNF Free Cash Flow Yield by quarter
Period	Free Cash Flow Yield
Jun 25	-1.36%
Jun 25	-1.32%
Jun 25	-1.32%
Jun 25	-1.37%
May 25	-1.37%
May 25	-1.37%
May 25	-1.37%
May 25	-1.4%
May 25	-1.11%
Apr 25	-1.11%
Apr 25	-1.11%
Apr 25	-1.11%
Apr 25	-1.11%
Mar 25	-2.04%
Mar 25	-2.04%
Mar 25	-2.04%
Mar 25	-2.04%
Feb 25	-2.04%
Feb 25	-2.04%
Feb 25	-2.04%
Feb 25	-2.04%
Jan 25	-2.04%
Jan 25	-2.28%
Jan 25	-2.3%
Jan 25	-2.17%
Jan 25	-2.18%
Dec 24	-2.17%
Dec 24	-2.31%
Dec 24	-2.71%
Dec 24	-2.71%
Nov 24	-2.71%
Nov 24	-2.71%
Nov 24	-2.71%
Nov 24	-2.71%
Nov 24	-2.71%
Oct 24	-2.71%
Oct 24	-2.71%
Oct 24	-2.71%
Oct 24	-2.71%
Sep 24	-3.92%
Sep 24	-3.92%
Sep 24	-3.92%
Sep 24	-3.92%
Aug 24	-3.92%
Aug 24	-3.92%
Aug 24	-4.12%
Aug 24	-4.12%
Aug 24	-4.12%
Jul 24	-4.39%
Jul 24	-4.44%
May 24	-5.52%
May 24	-5.52%
Mar 24	-6.62%
Feb 24	-6.49%
Feb 24	-6.49%
Feb 24	-6.49%
Feb 24	-7.02%
Feb 24	-7.02%
Jan 24	-7.02%
Jan 24	-7.02%
Jan 24	-7.02%
Dec 23	-6.85%
Nov 23	-5.03%
Oct 23	-5.05%
Oct 23	-5.61%
Jul 23	-6.33%
Jun 23	-6.11%
Jun 23	-6.12%
Oct 22	-6.17%
Jun 22	-4.42%
Jun 22	-4.86%
Jun 22	-4.72%
May 22	-5.38%
May 22	-5.13%
Feb 22	-3.52%
Feb 22	-3.77%
Jan 22	-3.95%
Jan 22	-3.44%
Jan 22	-3.02%
Dec 21	-3.4%
Nov 21	-3.79%
Nov 21	-3.5%
Oct 21	-3.73%
Oct 21	-3.54%
Sep 21	-3.46%
Sep 21	-1.32%
Sep 21	-1.27%
Aug 21	-1.35%
Jul 21	-1.38%
Jun 21	-1.33%
Mar 21	-0.22%
Mar 21	-0.2%
Dec 20	-0.22%
Sep 20	0.87%
Jul 20	0.79%
Jul 20	0.82%
Jun 20	0.89%
May 20	1.22%
May 20	1.39%
Apr 20	1.32%

Price to Sales

ARGNF Price to Sales by quarter
Period	Price to Sales
Sep 26	12.51
Sep 26	12.56
Aug 26	12.63
Aug 26	12.32
Aug 26	10.75
Aug 26	10.71
Jul 26	10.71
Jul 26	10.71
Jul 26	10.71
Jul 26	11.58
Jul 26	11.58
Jun 26	11.15
Jun 26	11.15
Jun 26	11.15
Jun 26	10.34
May 26	10.34
May 26	9.95
May 26	9.95
May 26	9.95
May 26	8.97
Apr 26	9.67
Apr 26	11.08
Apr 26	8.82
Apr 26	8.82
Mar 26	14.75
Mar 26	14.75
Mar 26	14.75
Mar 26	14.75
Feb 26	14.75
Feb 26	14.75
Feb 26	14.75
Feb 26	15.24
Jan 26	15.24
Jan 26	14.79
Jan 26	14.79
Jan 26	14.79
Jan 26	15.75
Dec 25	15.75
Dec 25	15.75
Dec 25	15.75
Dec 25	15.75
Nov 25	15.75
Nov 25	15.75
Nov 25	15.75
Nov 25	15.21
Oct 25	14.23
Oct 25	15.09
Oct 25	15.09
Oct 25	15.09
Oct 25	14.48
Sep 25	15.69
Sep 25	15.69
Sep 25	15.69
Sep 25	13.4
Aug 25	13.4
Aug 25	12.15
Aug 25	12.15
Aug 25	10.74
Aug 25	10.74
Jul 25	10.74
Jul 25	10.74
Jul 25	10.74
Jul 25	10.74
Jun 25	12.22
Jun 25	12.59
Jun 25	12.59
Jun 25	12.07
May 25	12.07
May 25	12.07
May 25	12.07
May 25	11.83
May 25	14.97
Apr 25	14.97
Apr 25	14.97
Apr 25	14.97
Apr 25	14.97
Mar 25	18.02
Mar 25	18.02
Mar 25	18.02
Mar 25	18.02
Feb 25	18.02
Feb 25	18.02
Feb 25	18.02
Feb 25	18.02
Jan 25	18.02
Jan 25	16.15
Jan 25	16.02
Jan 25	16.92
Jan 25	16.85
Dec 24	16.94
Dec 24	15.91
Dec 24	13.58
Dec 24	13.58
Nov 24	13.58
Nov 24	13.58
Nov 24	13.58
Nov 24	13.58
Nov 24	13.58
Oct 24	13.58
Oct 24	13.58

EV/EBITDA

ARGNF EV/EBITDA by quarter
Period	EV/EBITDA
Sep 26	41.51
Sep 26	41.69
Aug 26	41.94
Aug 26	40.84
Aug 26	35.23
Aug 26	35.09
Jul 26	35.09
Jul 26	35.09
Jul 26	35.09
Jul 26	38.2
Jul 26	38.2
Jun 26	36.64
Jun 26	36.64
Jun 26	36.64
Jun 26	33.77
May 26	33.77
May 26	32.36
May 26	32.36
May 26	32.36
May 26	28.89
Apr 26	31.38
Apr 26	36.41
Apr 26	28.33
Apr 26	28.33
Mar 26	89.34
Mar 26	89.34
Mar 26	89.34
Mar 26	89.34
Feb 26	89.34
Feb 26	89.34
Feb 26	89.34
Feb 26	92.56
Jan 26	92.56
Jan 26	89.57
Jan 26	89.57
Jan 26	89.57
Jan 26	95.89
Dec 25	95.89
Dec 25	95.89
Dec 25	95.89
Dec 25	95.89
Nov 25	95.89
Nov 25	95.89
Nov 25	95.89
Nov 25	92.32
Oct 25	85.9
Oct 25	91.55
Oct 25	91.55
Oct 25	91.55
Oct 25	87.56

Price/Operating Cashflow

ARGNF Price/Operating Cashflow by quarter
Period	Price/Operating Cashflow
Sep 20	98.04
Jul 20	107.05
Jul 20	103.98
Jun 20	95.78
May 20	69.53
May 20	61.08
Apr 20	64.59
Apr 20	56.48
Mar 20	30.12
Feb 20	32.36
Jan 20	35.64

Price to Book

ARGNF Price to Book by quarter
Period	Price to Book
Sep 26	8.47
Sep 26	8.51
Aug 26	8.55
Aug 26	8.34
Aug 26	7.28
Aug 26	7.25
Jul 26	7.25
Jul 26	7.25
Jul 26	7.25
Jul 26	7.84
Jul 26	7.84
Jun 26	7.55
Jun 26	7.55
Jun 26	7.55
Jun 26	7
May 26	7
May 26	6.74
May 26	6.74
May 26	6.74
May 26	6.08
Apr 26	6.55
Apr 26	7.5
Apr 26	5.97
Apr 26	5.97
Mar 26	8.16
Mar 26	8.16
Mar 26	8.16
Mar 26	8.16
Feb 26	8.16
Feb 26	8.16
Feb 26	8.16
Feb 26	8.43
Jan 26	8.43
Jan 26	8.18
Jan 26	8.18
Jan 26	8.18
Jan 26	8.71
Dec 25	8.71
Dec 25	8.71
Dec 25	8.71
Dec 25	8.71
Nov 25	8.71
Nov 25	8.71
Nov 25	8.71
Nov 25	8.41
Oct 25	7.87
Oct 25	8.35
Oct 25	8.35
Oct 25	8.35
Oct 25	8.01
Jun 25	6.19
Jun 25	6.38
Jun 25	6.38
Jun 25	6.12
May 25	6.12
May 25	6.12
May 25	6.12
May 25	6
May 25	7.59
Apr 25	7.59
Apr 25	7.59
Apr 25	7.59
Apr 25	7.59
Mar 25	9.72
Mar 25	9.72
Mar 25	9.72
Mar 25	9.72
Feb 25	9.72
Feb 25	9.72
Feb 25	9.72
Feb 25	9.72
Jan 25	9.72
Jan 25	8.71
Jan 25	8.64
Jan 25	9.13
Jan 25	9.09
Dec 24	9.14
Dec 24	8.58
Dec 24	7.32
Dec 24	7.32
Nov 24	7.32
Nov 24	7.32
Nov 24	7.32
Nov 24	7.32
Nov 24	7.32
Oct 24	7.32
Oct 24	7.32
Oct 24	7.32
Oct 24	7.32
Sep 24	7.48
Sep 24	7.48
Sep 24	7.48
Sep 24	7.48
Aug 24	7.47
Aug 24	7.47
Aug 24	7.11
Aug 24	7.11
Aug 24	7.11
Jul 24	6.68
Jul 24	6.61

No video analysis for this stock yet. Request one from our team.

News: ARGNF

businesswire.com · 2 Sep 2026

BenchSci Announces Two-Year Enterprise Agreement with argenx to Advance AI-Driven Preclinical Drug Discovery

TORONTO--(BUSINESS WIRE)--BenchSci, a leading provider of AI software for biopharma research and development, today announced a two-year enterprise agreement with argenx, a global immunology innovation company, to deploy EMET, BenchSci's agentic research environment for preclinical drug discovery, within the organization. Selected through a competitive evaluation led by argenx's own scientists, the agreement represents a significant milestone in BenchSci's expansion across European biopharma. U.

wsj.com · 27 Jul 2026

Argenx to Buy Forte Biosciences for $2.2 Billion

The deal to acquire the Nasdaq-listed Forte represents a 41% premium to its closing price on Friday.

reuters.com · 27 Jul 2026

Argenx to buy Forte Biosciences for about $2.2 billion

Belgian-Dutch immunology company argenx will buy ‌Forte Biosciences to add experimental autoimmune drug FB102 to its portfolio, ⁠the company said on Monday.

reuters.com · 23 Jul 2026

Argenx's Vyvgart sales jump in second quarter

Belgian-Dutch immunology company argenx said on Thursday global sales of its lead ‌drug Vyvgart jumped in the second quarter of 2026 from a year earlier.